Perineal talc use and ovarian cancer risk: A case study of scientific standards in environmental epidemiology

European Journal of Cancer Prevention

Volumn 20, Issue 6, 2011, Pages 501-507

  Huncharek, Michael ^a   Muscat, Joshua ^b  

^a Meta Analysis Research Group   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

causation; cosmetic talc; ovarian neoplasms; risk factors

Indexed keywords

TALC;

CANCER EPIDEMIOLOGY; CANCER RISK; CARCINOGENICITY; CASE CONTROL STUDY; FEMALE; HUMAN; OBSERVATIONAL STUDY; OVARY CANCER; PERINEUM; PRIORITY JOURNAL; REVIEW;

CASE-CONTROL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; OVARIAN NEOPLASMS; PERINEUM; TALC;

EID: 80053636002     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3283476242     Document Type: Review

References (38)

1. Boger-Megiddo I, Weiss NS (2005). Histologic subtypes and laterality of primary epithelial ovarian tumors. Gynecol Oncol 97:80-83. (Pubitemid 40403678)
2. Bonovas S, Filioussi K, Sitaras NM (2005). Do non-steroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysis. Br J Clin Pharmacol 60:194-203. (Pubitemid 41075905)
3. Booth M, Beral V, Smith P (1989). Risk factors for ovarian cancer: a case-control study. Br J Cancer 60:592-598. (Pubitemid 19251457)
4. Chang S, Risch HA (1997). Perineal talc exposure and risk of ovarian carcinoma. Cancer 79:2396-2401. (Pubitemid 27251024)
5. Chen Y, Wu PC, Lang JH, Ge WJ, Hartge P, Brinton LA (1992). Risk factors for epithelial ovarian cancer in Bejing China. Int J Epidemiol 21:23-29.
6. Cook LS, Kamb ML, Weiss NS (1997). Perineal powder exposure and the risk of ovarian cancer. Am J Epidemiol 145:459-465. (Pubitemid 27084218)
7. Cramer DW, Welch WR, Scully RE, Wojclechowski CA (1982). Ovarian cancer and talc: a case-control study. Cancer 50:372-376. (Pubitemid 12089403)
8. Cramer DW, Liberman RF, Titus-Ernstoff L, Welch WR, Greenberg ER, Baron JA, Harlow BL (1999). Genital talc exposure and risk of ovarian cancer. Int J Cancer 81:351-356. (Pubitemid 29165192)
9. Cramer DW, Titus-Ernstoff L, McKilanis JR, Welch WR, Vitonis AF, Berkowitz RS, Finn OJ (2005). Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev 14:1125-1131. (Pubitemid 40656457)
10. Epstein S. http://www.preventcancer.com, May 13, 2008.
11. Feinstein AR (1988). Scientific standards in epidemiologic studies of the menace of daily life. Science 242:1257-1263. (Pubitemid 19008055)
12. Gertig DM, Hunter DJ, Cramer DW, Colditz GA, Speizer FE, Willett WC, Hankinson SE (2000). Prospective study of talc use and ovarian cancer. J Natl Cancer Inst 92:249-252. (Pubitemid 30099784)
13. Godard B, Foulkes WD, Provencher D, Brunet JS, Tonin PN, Mes-Mason AM, et al. (1998). Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study. Obstet Gynecol 79:403-410. (Pubitemid 28413377)
14. Golf BA, Mandel LS, Melaneon CH, Munz HG (2004). Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA 291: 2705-2712. (Pubitemid 38725419)
15. Green A, Purdie D, Bain C, Siskind V, Russell P, Quinn M, Ward B (1997). Tubal sterilization, hysterectomy, and decreased risk of ovarian cancer. Survey of women's health study group. Int J Cancer 71:948-951. (Pubitemid 27252873)
16. Harlow BL, Cramer DW, Bell DA, Welch WR (1992). Perineal exposure to talc and ovarian cancer risk. Obstet Gynecol 80:19-26.
17. Huncharek M (1986). The biomedical and epidemiological characteristics of asbestos-related diseases: a review. Yale J Biol Med 59:435-451. (Pubitemid 17187221)
18. Huncharek M, Muscat J (2007). Use of cosmetic talc on contraceptive diaphragms and risk of ovarian cancer: a meta-analysis of nine observational studies. Eur J Cancer Prev 16:422-429. (Pubitemid 47550002)
19. Huncharek M, Muscat J, Kupelnick B. Smoking as a risk factor for epithelial ovarian cancer: a meta-analsysis of 13 330 cases from twenty-six observational studies. Carcinogenesis (in press).
20. Huncharek M, Geschwind GF, Kupelnick B (2003). Perineal application of cosmetic talc and risk of invasive epithelial ovarian cancer: a meta-analysis of 11 933 subjects from sixteen observational studies. Anti-Cancer Res 23:1955-1960. (Pubitemid 36750874)
21. Langseth H, Hankinson SE, Siemiatycki J, Weiderpass E (2008). Perineal use of talc and risk of ovarian cancer. J Epidemiol Community Health 62: 358-360. (Pubitemid 351441552)
22. Merritt MA, Green AC, Nagie CM, Webb PM (2008). Talcum powder, chronic pelvic inflammation and NSAIDS in relation to risk of epithelial ovarian cancer. Int J Cancer 122:170-176. (Pubitemid 350209992)
23. Muscat J, Huncharek M (2008). Perineal talc use and ovarian cancer: a critical review. Eur J Cancer Prev 17:139-146. (Pubitemid 351301625)
24. Najmunnisa N, Mohammed KA, Brown S, Su Y, Moudgil B, Loddenkemper R, Antony VB (2007). Talc mediates angiostasis in malignant pleural effusions via endostatin induction. Eur Resp J 29:761-769. (Pubitemid 46554628)
25. Ness RB, Cottreau C (1999). Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 91:1459-1467. (Pubitemid 29424550)
26. Pan SY, Ugnat AM, Mao Y, Wen SW, Johnson KC (2004). A case-control study of diet and the risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 13:1521-1527. (Pubitemid 39202321)
27. Paulsen T, Kaern J, Kjaerheim K, Trope C, Tretti S (2005). Symptoms and referral of women with epithelial ovarian tumors. Int J Gynecol Obstet 88:31-37. (Pubitemid 40023091)
28. Petitti D (2000). Meta-analysis, decision analysis and cost-effectiveness analysis: methods for quantitative synthesis in medicine. 2nd ed. New York: Oxford University Press.
29. Purdie D, Green A, Bain C, Siskind V, Ward B, Hackern N, et al. (1995). Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Int J Cancer. 62:678-684.
30. Richardson GS, Scully RE, Nirui N, Nelson JH (1985). Common epithelial cancer of the ovary. N Engl J Med 312:415-424.
31. Rohl AN, Langer AM, Selikoff IJ (1976). Consumer talcums and powders: mineral and chemical characteristics. J Toxicol Environ Health 2:255-284. (Pubitemid 8055658)
32. Rosenblatt KA, Mathews WA, Daling JR, Voigt LF, Malone K (1998). Characteristics of women who use perineal powders. Obstet Gynecol 92:753-756. (Pubitemid 28487669)
33. Rothman K (1986). Modern Epidemiology. Boston, Toronto: Little Brown and Co.; pp. 16-17.
34. Shaw P, Agarwal R (2004). Pleurodesis for malignant pleural effusions. Cochrane Database Systematic Rev 1:CD002916. DOI: 10.1002/14651858. CD009216.pub2.
35. Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E, Smith A (1981). Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst 67:965-975. (Pubitemid 12252082)
36. Tzonou A, Polychronopoulou A, Hsieh CC, Rebalakos A, Karakats A, Trichopoulos D (1993). Hair dyes, tranquilizers and perineal talc applicatin as a risk factor for ovarian cancer. Int J Cancer 55:408-410. (Pubitemid 23300589)
37. Whittemore AS, Wu ML, Paffenbarger RS, Sarles DL, Kampert JB, Grosser S, et al. (1998). Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol and coffee. Am J Epidemiol 128:1228-1246.
38. Wong C, Hempling RE, Pivers MS, Natarajan N, Mettlin CJ (1999). Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study. Obstet Gynecol 93:372-376. (Pubitemid 29106995)